Yvonne Remde
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Differential Radiobiological Effects of Αlpha- and Beta-Minus-Emitter Targeted Radionuclide Therapy: DNA Damage and Survival.
Journal: International journal of radiation oncology, biology, physics
Published: January 15, 2026
Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 03, 2025
Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 07, 2024
Synthesis of tritium-labeled Lu-PSMA-617: Alternative tool for biological evaluation of radiometal-based pharmaceuticals.
Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
Published: January 31, 2023
Development of PSMA-1007-Related Series of 18F-Labeled Glu-Ureido-Type PSMA Inhibitors.
Journal: Journal of medicinal chemistry
Published: August 28, 2020
Designing tracers for PET imaging of the urokinase-type plasminogen activator receptor from a cyclic uPA-derived peptide: first in vitro evaluations.
Journal: Journal of labelled compounds & radiopharmaceuticals
Published: February 25, 2019
Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 15, 2017
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 20, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026